| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0065 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |